Skip to content Skip to footer
Subscribe Now
Viewpoint_Fabian_Gerlinghaus_2020
VIEWPOINTS
PharmaShots Interview: Cellares’ Fabian Gerlighaus Shares Insight on Cell Shuttle
In a recent interview with PharmaShots, Fabian Gerlighaus, Co-Founder and CEO of Cellares, shared information on Cellares partnership with Fred Hutchinson Cancer Research Center and unveils how the company is working to get patients the cell therapies they need. Shots: Cellares collaboration with Fred Hutchinson Cancer Research Center is a part of EAPP. Fred Hutch will work closely…
December 14, 20200Comments
Thoughtspot_Dr. Sunaina Anand
THOUGHTSPOT
Digital Biomarkers
The Healthcare industry is going through a technological revolution and it is vital for the industry to work on new technologies that will help to generate, collect & track novel data. The availability of large data makes the system becomes important to convert it into appropriate information which will helps industry researchers, clinicians, doctors, entrepreneurs,…
December 14, 20200Comments
Generics Pharma Companies Top 20 2019
TOP 20
Top 20 Generics Pharma Companies Based On 2019 Revenue
The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs. Generics are approved copies of small molecule drugs that contain the same amount of active ingredients- dosage form- safety- strength- route of administration- quality-…
December 10, 20200Comments
ViewPoint_William_F_Doyle_2020
VIEWPOINTS
PharmaShots Interview: Novocure’s William F. Doyle Shares Insight on Company’s Accomplishments in the Treatment of Glioblastoma and Mesothelioma
In a recent interview with PharmaShots, William F. Doyle, Executive Chairman at Novocure shared information about the company's activities in the field of glioblastoma and mesothelioma. He also discussed the company's technology, Tumor Treating Fields (TTFields), and its potential for broad applicability across solid tumors. Shots: Novocure is a global oncology company working to extend survival…
December 9, 20200Comments
Viewpoints_Andrea Taylor
VIEWPOINTS
PharmaShots Interview: Duke’s Andrea Taylor Shares Insight on Launch And Scale Speedometer
In a recent interview with PharmaShots, Andrea Taylor, Researcher at Launch And Scale  Speedometer shared her insights and highlights on data how rich countries shopping spree for COVID-19 vaccines means fewer vaccinations for billions in low-income countries Shots: The Launch and Scale Speedometer project aims to systematically analyze the factors that support or hinder the introduction and scaling of interventions,…
December 8, 20200Comments
Viewpoint_Peony_Yu_2020
VIEWPOINTS
PharmaShots Interview: FibroGen’s Peony Yu Shares Insight on Roxadustat
In a recent interview with PharmaShots, Peony Yu, Chief Medical Officer of FibroGen shared her insights and highlights on data of Roxadustat Shots: FibroGen presented new efficacy and safety analyses from the roxadustat global P-III program at ASN Kidney Week 2020 Reimagined. FibroGen and its partners, AstraZeneca and Astellas, presented 42 abstracts, including 2 late-breaker poster presentations,…
December 7, 20200Comments
Viewpoint_Julie_Foster_2020
VIEWPOINTS
PharmaShots Interview: Medtronic’s Julie Foster Shares Insight on InPen Integrated with Guardian Connect CGM
In a recent interview with PharmaShots, Julie Foster, Vice President, Global Customer Experience of the Diabetes business at Medtronic, shares information about recent and upcoming announcements for the company. Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical's InPen to the Medtronic portfolio, as of Sept'2020 The…
December 2, 20200Comments

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]